Business Context and Reporting Period
Company: Deckers Outdoor Corporation
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2005
Business Overview: Deckers is a designer, producer, and brand manager of innovative footwear, operating three primary proprietary brands: Teva (outdoor lifestyle/sport sandals), UGG (luxury sheepskin footwear), and Simple (casual "anti-brand" footwear). The company sells through domestic retailers, international distributors, and a Consumer Direct division (Internet, catalog, and retail outlets). All manufacturing is outsourced to independent contractors, primarily in the Far East.
Key Financial Metrics (Fiscal Year 2005)
| Metric | 2005 Value | 2004 Value |
|---|---|---|
| Net Sales | $264,760,000 | $214,787,000 |
| Gross Profit | $111,522,000 | $90,433,000 |
| Gross Margin | 42.1% | 42.1% |
| Income from Operations | $52,268,000 | $42,462,000 |
| Operating Margin | 19.7% | 19.8% |
| Net Income | $31,845,000 | $25,539,000 |
| Diluted EPS | $2.48 | $2.10 |
| Cash and Cash Equivalents | $50,749,000 | $10,379,000 |
| Working Capital | $107,120,000 | $69,854,000 |
| Long-Term Debt | $0 | $0 |
| Revolving Credit Facility Availability | $19,948,000 | N/A |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 23.3% to $264.8 million, driven primarily by a 47.6% surge in UGG wholesale sales ($150.3 million) and a 36.2% increase in Consumer Direct sales ($27.1 million).
- Brand Performance Divergence:
- UGG: Continued explosive growth due to celebrity endorsement, expanded product lines (Spring/Fall collections), and improved inventory availability.
- Teva: Wholesale sales declined 3.6% to $80.4 million due to an unseasonably cold Spring 2005, increased competition, and a lack of recent product innovation.
- Simple: Wholesale sales decreased 27.5% to $7.0 million following the discontinuation of the "Simple Sheep" product line, though core sneaker and clog categories grew.
- International Sales: Decreased 10.4% to $35.3 million (13.3% of total sales), attributed to declines in the European market for both Teva and UGG.
- Liquidity: Cash and cash equivalents grew significantly from $10.4 million to $50.7 million, fueled by strong operating cash flow ($29.6 million) and the sale of short-term investments.
- Debt: The company remains debt-free regarding long-term obligations. All borrowings from the 2002 Teva acquisition were repaid in 2004.
Guidance, Outlook, and Risks
Management Commentary and Outlook
- Teva Strategy: Management anticipates continued challenges in 2006 but expects a return to growth by Spring 2007 following increased investment in product development and international infrastructure.
- UGG Strategy: The company plans to prolong the brand's longevity by expanding product lines for different climates (e.g., open-toe sandals for Spring 2006) and limiting distribution to high-end retailers to maintain luxury positioning.
- International Expansion: A new international organization reporting to the CEO was established in late 2005, with plans to open offices in Europe and Asia to coordinate sales and marketing.
- Licensing: Licensing revenues are currently immaterial ($1.1 million in 2005) but are expected to grow over time as new agreements for handbags, outerwear, and accessories mature.
Risks and Contingencies
- Supply Chain Constraints: UGG relies on top-grade sheepskin, which is in limited supply and subject to price volatility, disease (hoof and mouth), and drought. Four suppliers provide all sheepskin for UGG products.
- Intellectual Property: Significant challenges exist regarding the "UGG" trademark in Australia, where local manufacturers claim the term is generic. The company faces ongoing litigation and enforcement costs globally to combat counterfeiting.
- Customer Concentration: The five largest customers accounted for 27.0% of net sales in 2005. A single West Coast department store accounted for 15.8% of total sales.
- Seasonality: Sales are highly seasonal; Teva peaks in Q1/Q2, while UGG peaks in Q3/Q4. Weather conditions significantly impact demand.
- Manufacturing Risks: All production is outsourced, primarily to four factories in China, exposing the company to trade barriers, currency fluctuations, and political instability.
Investor Verification Checklist
- UGG Sustainability: Verify if the 47.6% growth rate in UGG sales is sustainable or if it represents a peak in a fashion cycle, given the company's own warning that growth rates may not be maintained.
- Sheepskin Supply: Monitor the availability and pricing of top-grade sheepskin, as shortages could disrupt UGG production and margins.
- Teva Turnaround: Assess the effectiveness of new product launches and marketing initiatives in reversing the 3.6% decline in Teva wholesale sales.
- Trademark Litigation: Track the status of UGG trademark disputes in Australia and other international jurisdictions, as loss of rights could materially impact the brand.
- Customer Concentration: Evaluate the financial health of the top five customers, particularly the single customer representing 15.8% of sales.
- Inventory Levels: Review inventory turnover ratios, noting the decrease from 5.5 times in 2004 to 3.2 times in 2005, to ensure excess inventory does not lead to future write-downs.